The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.
A sweeping “Made in America” executive order from President Joe Biden aims to, among other things, give smaller US manufacturers and vendors a leg up over foreign competitors.
The 25 January executive order says federal agencies should partner with the Hollings Manufacturing Extension Partnership (MEP) to “conduct...
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
An upcoming US FDA advisory panel meeting will discuss adding a new indication to allow dermal fillers to be used in the upper chest, or décolletage. Plastic surgeons expect this could drive interest in the procedure, which is already performed off-label.
